Average Co-Inventor Count = 12.61
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Pharma Aktiengesellschaft (16 from 378 patents)
2. Bayer Aktiengesellschaft (8 from 12,160 patents)
3. The Broad Institute, Inc. (8 from 443 patents)
4. Bayer Intellectual Property Gmbh (5 from 721 patents)
5. Bayer Schering Pharma Ag (5 from 192 patents)
6. Other (1 from 832,843 patents)
7. Schering Aktiengesellschaft (1 from 1,384 patents)
8. Dana-farber-cancer Institute Inc. (1 from 1,209 patents)
27 patents:
1. 12338250 - Methods of preparing macrocyclic indoles
2. 12227501 - 3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitors
3. 12152041 - Macrocyclic fluorine substituted indole derivatives
4. 11891404 - Substituted macrocyclic indole derivatives
5. 11478451 - Macrocyclic chlorine substituted indole derivatives
6. 11447504 - Macrocyclic chlorine substituted indole derivatives
7. 11440923 - Substituted macrocyclic indole derivatives
8. 11401278 - Macrocyclic indole derivatives
9. 11286263 - Macrocyclic fluorine substituted indole derivatives
10. 10894784 - Heteroarylbenzimidazole compounds
11. 10604532 - Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases
12. 10350206 - Benzyl substituted indazoles as BUB1 inhibitors
13. 10266548 - Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases
14. 9765058 - Substituted benzylpyrazoles
15. 9745285 - Heteroaryl substituted pyrazoles